Rocket Pharmaceuticals Inc (RCKT)

$4.39 -0.08 (-1.79%)
Market Cap 485.30M
Revenue (ttm) 0.00
Net Income (ttm) -223.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,077,900
Avg Vol 2,611,744
Day's Range N/A - N/A
Shares Out 108.57M
Stochastic %K 17%
Beta 0.39
Analysts Sell
Price Target $8.20

Company Profile

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogeni...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 659 8001
Address:
9 Cedarbrook Drive, Cranbury, United States
Smellmahass
Smellmahass Mar. 20 at 7:47 AM
$DNLI This and $RCKT. They only use single arm so why would fda approve them? Fda declined rgnx and atra based on being single arm right?
0 · Reply
Stephanovich7654568
Stephanovich7654568 Mar. 20 at 2:15 AM
$RCKT Today, during the day, around $12 millions dollars worth of trade exchange. And it's almost like that everyday. When this RCKT pops up it's going to be like fireworks. I don't know who's in the kitchen. I don't know what's cooking. But it shure start to smell good. Sleep well, sleep tight. No worry. ❤️❤️❤️❤️❤️🌛🌟🪐❤️❤️❤️❤️❤️
0 · Reply
Stephanovich7654568
Stephanovich7654568 Mar. 20 at 2:06 AM
$RCKT Who buy for $250,000 in the after-hours. I've seen a lot of these.
1 · Reply
longDstyle
longDstyle Mar. 19 at 10:23 PM
$RCKT added another 2500 shares. RCKT and IMRX are 2 that have great potential in the near term
1 · Reply
alotobeer
alotobeer Mar. 19 at 9:22 PM
$RCKT get in and shut up
1 · Reply
HeekLikeThis
HeekLikeThis Mar. 19 at 8:20 PM
$RCKT On March 28, we could see a potential +80% to +150% move. 🚀🍀💚
2 · Reply
basssque
basssque Mar. 19 at 8:10 PM
$CING $RCKT $GRCE $AQST 1.💰2.💰3.💰4.💰
1 · Reply
Resilience1239
Resilience1239 Mar. 19 at 7:59 PM
$RCKT https://www.youtube.com/watch?v=diLPA8mXHf0
0 · Reply
Resilience1239
Resilience1239 Mar. 19 at 7:12 PM
$RCKT I may be a small fish here, but I'm in for total 3000 shares as of today. Lets go! March 30th we going to $15-$20.
3 · Reply
Stephanovich7654568
Stephanovich7654568 Mar. 19 at 5:37 PM
$RCKT 😉
0 · Reply
Latest News on RCKT
Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 6, 2026, 1:56 PM EST - 13 days ago

Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress

Feb 26, 2026, 4:00 PM EST - 21 days ago

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Feb 23, 2026, 7:00 AM EST - 24 days ago

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 5:16 PM EST - 2 months ago

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 7:00 AM EST - 2 months ago

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program

Dec 26, 2025, 10:23 AM EST - 2 months ago

Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Nov 25, 2025, 7:00 AM EST - 4 months ago

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Nov 6, 2025, 4:00 PM EST - 4 months ago

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock

Oct 14, 2025, 2:27 PM EDT - 5 months ago

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Oct 14, 2025, 7:00 AM EDT - 5 months ago

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 10, 2025, 4:00 PM EDT - 5 months ago

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder

Oct 3, 2025, 7:11 AM EDT - 5 months ago

Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder

Rocket Pharmaceuticals, Inc. (RCKT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 12:36 PM EDT - 6 months ago

Rocket Pharmaceuticals, Inc. (RCKT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed.

Aug 20, 2025, 11:02 AM EDT - 7 months ago

Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed.

FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy

Aug 20, 2025, 9:31 AM EDT - 7 months ago

FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

Aug 20, 2025, 7:09 AM EDT - 7 months ago

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

Aug 20, 2025, 7:00 AM EDT - 7 months ago

Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025

Aug 8, 2025, 2:16 PM EDT - 7 months ago

DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025

Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress

Aug 7, 2025, 4:00 PM EDT - 8 months ago

Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 30, 2025, 6:29 PM EDT - 8 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

Jul 30, 2025, 11:07 AM EDT - 8 months ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT CABA NGNE NTLA QURE

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 29, 2025, 10:26 AM EDT - 8 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

Jul 25, 2025, 3:02 PM EDT - 8 months ago

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT

Jul 24, 2025, 4:02 PM EDT - 8 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

Jul 24, 2025, 7:00 AM EDT - 8 months ago

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

Jul 17, 2025, 7:00 AM EDT - 8 months ago

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 11, 2025, 10:25 AM EDT - 8 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

Jul 9, 2025, 5:16 PM EDT - 9 months ago

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT

Jul 7, 2025, 9:00 AM EDT - 9 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

Jun 30, 2025, 7:00 AM EDT - 9 months ago

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

Smellmahass
Smellmahass Mar. 20 at 7:47 AM
$DNLI This and $RCKT. They only use single arm so why would fda approve them? Fda declined rgnx and atra based on being single arm right?
0 · Reply
Stephanovich7654568
Stephanovich7654568 Mar. 20 at 2:15 AM
$RCKT Today, during the day, around $12 millions dollars worth of trade exchange. And it's almost like that everyday. When this RCKT pops up it's going to be like fireworks. I don't know who's in the kitchen. I don't know what's cooking. But it shure start to smell good. Sleep well, sleep tight. No worry. ❤️❤️❤️❤️❤️🌛🌟🪐❤️❤️❤️❤️❤️
0 · Reply
Stephanovich7654568
Stephanovich7654568 Mar. 20 at 2:06 AM
$RCKT Who buy for $250,000 in the after-hours. I've seen a lot of these.
1 · Reply
longDstyle
longDstyle Mar. 19 at 10:23 PM
$RCKT added another 2500 shares. RCKT and IMRX are 2 that have great potential in the near term
1 · Reply
alotobeer
alotobeer Mar. 19 at 9:22 PM
$RCKT get in and shut up
1 · Reply
HeekLikeThis
HeekLikeThis Mar. 19 at 8:20 PM
$RCKT On March 28, we could see a potential +80% to +150% move. 🚀🍀💚
2 · Reply
basssque
basssque Mar. 19 at 8:10 PM
$CING $RCKT $GRCE $AQST 1.💰2.💰3.💰4.💰
1 · Reply
Resilience1239
Resilience1239 Mar. 19 at 7:59 PM
$RCKT https://www.youtube.com/watch?v=diLPA8mXHf0
0 · Reply
Resilience1239
Resilience1239 Mar. 19 at 7:12 PM
$RCKT I may be a small fish here, but I'm in for total 3000 shares as of today. Lets go! March 30th we going to $15-$20.
3 · Reply
Stephanovich7654568
Stephanovich7654568 Mar. 19 at 5:37 PM
$RCKT 😉
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Mar. 19 at 5:35 PM
$RCKT $GRCE you two girls competing for me?
1 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Mar. 19 at 4:51 PM
$RCKT
0 · Reply
BanditKnight47
BanditKnight47 Mar. 19 at 3:30 PM
$RCKT suddenly goes up before Friday...🙄
1 · Reply
JD101
JD101 Mar. 19 at 3:19 PM
$RCKT nice flush sub $4.50
0 · Reply
inquisitive30
inquisitive30 Mar. 19 at 3:12 PM
$RCKT Wake me up at the dip to $4.00
1 · Reply
Sciencefiction666
Sciencefiction666 Mar. 19 at 3:09 PM
$RCKT At least our arms are going to be ripped due to holding these bags! Always a silver lining.
1 · Reply
RickyIsRich
RickyIsRich Mar. 19 at 2:35 PM
$RCKT hopefully u guys took advantage of the 6% dippy 🔥🚀
0 · Reply
Teillbou
Teillbou Mar. 19 at 2:33 PM
$RCKT
0 · Reply
Bellz22
Bellz22 Mar. 19 at 1:51 PM
$RCKT nothing to look at today . Market is cooked. Thank you trump you orange piece of shit
1 · Reply
RickyIsRich
RickyIsRich Mar. 19 at 1:37 PM
$RCKT whole market getting shot down doesn’t changed the thesis
1 · Reply
RickyIsRich
RickyIsRich Mar. 19 at 1:00 PM
$RCKT a lot of red days recently gonna keep averaging down
1 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Mar. 19 at 12:04 PM
$RCKT
1 · Reply